Ms. Melinda Rombouts reports

EVE & CO ANNOUNCES EXERCISE OF WARRANTS, FURTHER STRENGTHENS BALANCE SHEET

Eve & Co. Inc. has seen 16,665,000 of its June, 2018, common share purchase warrants exercised for proceeds to the company of approximately $5.8-million. The warrants were issued in June, 2018, and were not set to expire until June, 2020.

"The proceeds from this warrant exercise, together with the proceeds from the recent conversion of the outstanding debentures and the expected proceeds from the recently announced special warrant bought deal, will further strengthen our balance sheet and provide capital to support the development of a female-focused consumer packaged goods program," stated Melinda Rombouts, chief executive officer of Eve & Co.

About Eve & Co. Inc.

Eve & Co., through its wholly owned subsidiary Natural MedCo Ltd., holds cultivation and processing licences under the Cannabis Act (Canada) for the production and sale of various cannabis products, including dried cannabis, cannabis plants and cannabis oil. Natural MedCo Ltd. was Canada's first female-founded licensed producer of medicinal marijuana and received its cultivation licence from Health Canada in 2016. Eve & Co. is led by a team of agricultural experts and has a licensed 220,000-square-foot scalable greenhouse production facility located in Middlesex county, Ontario, with 32 acres of adjacent land for future expansion. Eve & Co. has commenced construction of an additional 780,000 sq ft proposed expansion, bringing Eve & Co.'s total anticipated greenhouse capacity to one million sq ft.

We seek Safe Harbor.